Skip to content
The Chat Archive
gpt-4-1106-preview· OpenAI Arena Human Preference 55K

what is bnt162b2

  1. User

    what is bnt162b2

  2. Assistant

    BNT162b2 is the technical name for the mRNA-based COVID-19 vaccine developed by Pfizer, Inc. and BioNTech SE. It is more commonly referred to as the Pfizer-BioNTech COVID-19 vaccine. This vaccine was among the first to receive emergency use authorization (EUA) by various health agencies around the world, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to prevent COVID-19 caused by the SARS-CoV-2 virus.

    The vaccine works by using a small piece of the SARS-CoV-2 virus's messenger RNA (mRNA) to instruct cells in the body to produce a modified form of the spike protein that is present on the surface of the virus. This protein alone cannot cause COVID-19, but it triggers an immune response that can recognize and fight the actual virus if the body is exposed to it in the future.

    BNT162b2 is administered in two doses, typically three weeks apart, and has been shown to have high efficacy in preventing COVID-19, as well as reducing the severity of the disease in cases where people do get infected after vaccination. It has played a significant role in the global efforts to combat the COVID-19 pandemic.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.